251 related articles for article (PubMed ID: 19133303)
1. Pharmacokinetics and pharmacogenomics in gastric cancer chemotherapy.
Nishiyama M; Eguchi H
Adv Drug Deliv Rev; 2009 May; 61(5):402-7. PubMed ID: 19133303
[TBL] [Abstract][Full Text] [Related]
2. Expert opinion on management of gastric and gastro-oesophageal junction adenocarcinoma on behalf of the European Organisation for Research and Treatment of Cancer (EORTC)-gastrointestinal cancer group.
Van Cutsem E; Van de Velde C; Roth A; Lordick F; Köhne CH; Cascinu S; Aapro M;
Eur J Cancer; 2008 Jan; 44(2):182-94. PubMed ID: 18093827
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics and pharmacogenomics in breast cancer chemotherapy.
Marsh S; Liu G
Adv Drug Deliv Rev; 2009 May; 61(5):381-7. PubMed ID: 19100797
[TBL] [Abstract][Full Text] [Related]
4. New chemotherapy strategies for gastric cancer.
Kubota T
In Vivo; 2008; 22(3):273-8. PubMed ID: 18610735
[TBL] [Abstract][Full Text] [Related]
5. Pharmacogenomics and -genetics in colorectal cancer.
Pohl A; Lurje G; Manegold PC; Lenz HJ
Adv Drug Deliv Rev; 2009 May; 61(5):375-80. PubMed ID: 19100300
[TBL] [Abstract][Full Text] [Related]
6. The role of chemotherapy for metastatic gastric cancer.
O'Brien ME; Cunningham D
J Infus Chemother; 1995; 5(3):112-6. PubMed ID: 8528967
[TBL] [Abstract][Full Text] [Related]
7. Chemotherapy for locally advanced and metastatic gastric cancer: state of the art and future perspectives.
Bittoni A; Maccaroni E; Scartozzi M; Berardi R; Cascinu S
Eur Rev Med Pharmacol Sci; 2010 Apr; 14(4):309-14. PubMed ID: 20496540
[TBL] [Abstract][Full Text] [Related]
8. Pharmacogenetics of fluoropyrimidine and cisplatin. A future application to gastric cancer treatment.
Shimoyama S
J Gastroenterol Hepatol; 2009 Jun; 24(6):970-81. PubMed ID: 19638079
[TBL] [Abstract][Full Text] [Related]
9. [Chemotherapy for advanced gastric cancer--our possibilities in 2007].
Dank M; Torgyík L; Szentmártoni G
Magy Onkol; 2007; 51(3):209-17. PubMed ID: 17922060
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics and pharmacogenomics in esophageal cancer chemoradiotherapy.
Sakaeda T; Yamamori M; Kuwahara A; Nishiguchi K
Adv Drug Deliv Rev; 2009 May; 61(5):388-401. PubMed ID: 19135108
[TBL] [Abstract][Full Text] [Related]
11. [Clinical development of chemotherapy for advanced gastric cancer].
Sato A; Nakamachi M
Gan To Kagaku Ryoho; 2008 Sep; 35(9):1461-6. PubMed ID: 18799898
[TBL] [Abstract][Full Text] [Related]
12. Adjuvant therapy in gastric and cardia cancer: should we irradiate?
Van Laethem JL; Demols A
Curr Opin Oncol; 2006 Jul; 18(4):381-5. PubMed ID: 16721135
[TBL] [Abstract][Full Text] [Related]
13. Gastric cancer pharmacogenetics: progress or old tripe?
Patel JN; Fuchs CS; Owzar K; Chen Z; McLeod HL
Pharmacogenomics; 2013 Jul; 14(9):1053-64. PubMed ID: 23837480
[TBL] [Abstract][Full Text] [Related]
14. [The current situation and subjects of the intraperitoneal chemotherapy for peritoneal dissemination in gastric cancer].
Hirono Y; Fujimoto D; Nagano H; Murakami M; Katayama K; Yamaguchi A
Gan To Kagaku Ryoho; 2008 Jun; 35(6):891-5. PubMed ID: 18633215
[TBL] [Abstract][Full Text] [Related]
15. [Pharmacogenomics of the first-line treatment for gastric cancer: advances in the identification of genomic biomarkers for clinical response to chemotherapy].
Castro-Rojas C; Ortiz-Lópezj R; Rojas-Martínez A
Invest Clin; 2014 Jun; 55(2):185-202. PubMed ID: 24974634
[TBL] [Abstract][Full Text] [Related]
16. Docetaxel: its role in current and future treatments for advanced gastric cancer.
Nishiyama M; Wada S
Gastric Cancer; 2009; 12(3):132-41. PubMed ID: 19890692
[TBL] [Abstract][Full Text] [Related]
17. Pharmacogenetics and stomach cancer: an update.
Toffoli G; Cecchin E
Pharmacogenomics; 2007 May; 8(5):497-505. PubMed ID: 17465714
[TBL] [Abstract][Full Text] [Related]
18. Individualized chemotherapy treatment for breast cancer: is it necessary? Is it feasible?
Pusztai L; Rouzier R; Wagner P; Symmans WF
Drug Resist Updat; 2004 Dec; 7(6):325-31. PubMed ID: 15790543
[TBL] [Abstract][Full Text] [Related]
19. Biomarkers of response to therapy in oesophago-gastric cancer.
Fareed KR; Kaye P; Soomro IN; Ilyas M; Martin S; Parsons SL; Madhusudan S
Gut; 2009 Jan; 58(1):127-43. PubMed ID: 19091831
[TBL] [Abstract][Full Text] [Related]
20. Pharmacogenomics of colorectal cancer prevention and treatment.
Nguyen H; Tran A; Lipkin S; Fruehauf JP
Cancer Invest; 2006 Oct; 24(6):630-9. PubMed ID: 16982469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
